132 related articles for article (PubMed ID: 20158204)
21. High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.
Khroyan TV; Yasuda D; Toll L; Polgar WE; Zaveri NT
Biochem Pharmacol; 2015 Oct; 97(4):531-541. PubMed ID: 26256075
[TBL] [Abstract][Full Text] [Related]
22. Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine.
Hauser TA; Hepler CD; Kombo DC; Grinevich VP; Kiser MN; Hooker DN; Zhang J; Mountfort D; Selwood A; Akireddy SR; Letchworth SR; Yohannes D
Neuropharmacology; 2012 Jun; 62(7):2239-50. PubMed ID: 22306792
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.
Crestey F; Jensen AA; Borch M; Andreasen JT; Andersen J; Balle T; Kristensen JL
J Med Chem; 2013 Dec; 56(23):9673-82. PubMed ID: 24187998
[TBL] [Abstract][Full Text] [Related]
24. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.
Cohen C; Bergis OE; Galli F; Lochead AW; Jegham S; Biton B; Leonardon J; Avenet P; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Voltz C; Gardes A; Caille D; Perrault G; George P; Soubrie P; Scatton B
J Pharmacol Exp Ther; 2003 Jul; 306(1):407-20. PubMed ID: 12682217
[TBL] [Abstract][Full Text] [Related]
25. Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.
Dwoskin LP; Sumithran SP; Zhu J; Deaciuc AG; Ayers JT; Crooks PA
Bioorg Med Chem Lett; 2004 Apr; 14(8):1863-7. PubMed ID: 15050617
[TBL] [Abstract][Full Text] [Related]
26. 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs.
Abdrakhmanova GR; Damaj MI; Carroll FI; Martin BR
Mol Pharmacol; 2006 Jun; 69(6):1945-52. PubMed ID: 16505153
[TBL] [Abstract][Full Text] [Related]
27. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, nicotinic acetylcholine receptor binding, in vitro and in vivo pharmacology properties of 3'-(substituted pyridinyl)-deschloroepibatidine analogs.
Ondachi PW; Ye Z; Castro AH; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
Bioorg Med Chem; 2015 Sep; 23(17):5693-701. PubMed ID: 26233800
[TBL] [Abstract][Full Text] [Related]
29. Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
Matera C; Quadri M; Sciaccaluga M; Pomè DY; Fasoli F; De Amici M; Fucile S; Gotti C; Dallanoce C; Grazioso G
Eur J Med Chem; 2016 Jan; 108():392-405. PubMed ID: 26706350
[TBL] [Abstract][Full Text] [Related]
30. alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues.
Briggs CA; Schrimpf MR; Anderson DJ; Gubbins EJ; Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Malysz J; Li J; Bunnelle WH; Gopalakrishnan M; Meyer MD
Br J Pharmacol; 2008 Mar; 153(5):1054-61. PubMed ID: 18157163
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
Damaj MI; Slemmer JE; Carroll FI; Martin BR
J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
Carroll FI; Ma W; Yokota Y; Lee JR; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
J Med Chem; 2005 Feb; 48(4):1221-8. PubMed ID: 15715488
[TBL] [Abstract][Full Text] [Related]
33. Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors.
García-Colunga J; Godoy-García U; Vázquez-Gómez E
Neuropharmacology; 2011 Dec; 61(8):1202-9. PubMed ID: 21791218
[TBL] [Abstract][Full Text] [Related]
34. α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X; You S; Xiong J; Qiao Y; Yu J; Zhangsun D; Luo S
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339145
[TBL] [Abstract][Full Text] [Related]
35. Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.
Carroll FI; Blough BE; Mascarella SW; Navarro HA; Eaton JB; Lukas RJ; Damaj MI
J Med Chem; 2010 Dec; 53(23):8345-53. PubMed ID: 21058665
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
[TBL] [Abstract][Full Text] [Related]
37. The anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptors.
Zheng C; Yang K; Liu Q; Wang MY; Shen J; Vallés AS; Lukas RJ; Barrantes FJ; Wu J
J Pharmacol Exp Ther; 2010 Nov; 335(2):401-8. PubMed ID: 20688974
[TBL] [Abstract][Full Text] [Related]
38. The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
McCaul ME; Wand GS; Kuwabara H; Dannals RF; Wong D; Xu X
Nicotine Tob Res; 2020 May; 22(6):892-899. PubMed ID: 31096265
[TBL] [Abstract][Full Text] [Related]
39. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
[TBL] [Abstract][Full Text] [Related]
40. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
